Lupin Ltd (LUPN.BO)
28 Apr 2017
* Lupin clarifies on news item, "Lupin's Goa plant receives adverse FDA observations".
* Says Lupin receives FDA approval for generic benicar tablets
* Says drug indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection
* Says lupin receives FDA approval for generic Tobi® inhalation solution
* Says Lupin launches generic Minastrin 24 Fe chewable tablets in the US
* Says Lupin launches hydrocodone bitartrate and acetaminophen tablets in the U.S.
* Drug indicated to treat major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder Source text: http://bit.ly/2n9awVy Further company coverage:
* Says tablets are indicated for the treatment of major depressive disorder Source text: http://bit.ly/2mgR90c Further company coverage:
* Says Lupin launches generic Temovate® Clobetasol Propionate scalp application in the US
* Received final approval for its Oxycodone and Acetaminophen tablets USP, 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg from USFDA